Karray O, Saadi A, Chakroun M, Ayed H, Cherif M, Bouzouita A, Slama M R B, Derouiche A, Chebil M
Urology department, Charles Nicolle hospital, Faculty of Medecine of Tunis, Tunis El Manar University, Tunis, Tunisia.
Prog Urol. 2018 Sep;28(10):488-494. doi: 10.1016/j.purol.2018.06.003. Epub 2018 Jul 5.
Paragangliomas, defined as extra-adrenal chromaffin-cells tumors, are rarely located in the retro-peritoneum. Clinical presentation is similar to pheochromocytoma, and mainly depends on the producing character of the tumor. Positive diagnosis requires plasmatic and urinary hormonal assays. Radiological and isotopic explorations are essential before surgery. The only curative therapeutic strategy is surgical, associated to peri-operative prevention and monitoring of the frequently reported hemodynamic and cardiovascular disorders. Outcome depends of the metastatic character of the tumor, the presence of tumor remnant after surgical resection. Genetic study is recommended; the risk of recurrence and association to other neoplasm is more described in genetic forms.
Authors report 5cases of retro-peritoneal paraganglioma, operated in the department of urology of Hospital, between 2013 and 2017. Observations are about 2men and 3women. Clinical presentation is not always specific and paraganglioma may be discovered fortuitously. Two patients have been operated by coelioscopic approach, midline incision was performed in two other cases, and dorsal lumbotomy associated to a Rutherford-Morrison incision in a patient.
Two patients presented resistant hypertension and palpitation associated to suspect retro-peritoneal masses in imagery and elevated urinary methoxylated derivates before surgery. One patient was asymptomatic and the tumor was discovered in imagery. Per-operative hypertensive crisis and sinus tachycardia occurred in a case. The average follow-up period is 22.8months. Hypertension and palpitation disappeared after surgery. There was no recurrence for all the operated patients.
Retro-peritoneal paraganglioma is a rare condition. Symptoms are not specific and clinical presentation may be similar to pheochromocytoma. Abdominal CT-scan and MRI, in association with MIBG scintigraphy are strongly evocative. Histological examination ensures diagnosis. Per-operative cardio-vascular disorders are to consider and must prevented and managed by anesthesiologists. Complete surgical resection is the only curative treatment and avoids recurrences.
副神经节瘤被定义为肾上腺外嗜铬细胞瘤,很少位于腹膜后。临床表现与嗜铬细胞瘤相似,主要取决于肿瘤的分泌特性。阳性诊断需要进行血浆和尿液激素检测。手术前,放射学和同位素检查至关重要。唯一的治愈性治疗策略是手术,并结合围手术期对常见的血流动力学和心血管疾病的预防及监测。预后取决于肿瘤的转移特性、手术切除后肿瘤残余的存在情况。建议进行基因研究;在基因形式中,复发风险和与其他肿瘤的关联更为常见。
作者报告了2013年至2017年期间在医院泌尿外科手术的5例腹膜后副神经节瘤病例。观察对象包括2名男性和3名女性。临床表现并不总是具有特异性,副神经节瘤可能是偶然发现的。2例患者通过腹腔镜手术,另外2例采用中线切口,1例患者采用背腰部切开术并联合鲁塞尔-莫里森切口。
2例患者术前出现难治性高血压和心悸,影像学检查怀疑腹膜后肿块,尿中甲基化衍生物升高。1例患者无症状,肿瘤在影像学检查中被发现。1例患者术中出现高血压危象和窦性心动过速。平均随访期为22.8个月。术后高血压和心悸消失。所有手术患者均未复发。
腹膜后副神经节瘤是一种罕见疾病。症状不具特异性,临床表现可能与嗜铬细胞瘤相似。腹部CT扫描和MRI结合间碘苄胍闪烁显像具有强烈的提示作用。组织学检查可确诊。术中应考虑心血管疾病,麻醉医生必须对其进行预防和处理。完整的手术切除是唯一的治愈性治疗方法,可避免复发。